Skip to main content
Premium Trial:

Request an Annual Quote

Support From Many Sources

US Vice President Joe Biden is eyeing private money to help support his cancer moonshot initiative, Stat News reports.

While the Obama administration is seeking some $755 million in funding for the project, Congressional Republicans have said they won't simply hand the funds over. Further, Biden's tenure there is winding down. To supplement that funding, Biden is drawing inspiration from the new immunotherapy institute at Johns Hopkins University, Stat News says.

This $125 million Bloomberg–Kimmel Institute for Cancer Immunotherapy is supported by two $50 million philanthropic donations, one from Michael R. Bloomberg, the former mayor of New York, and another from Sidney Kimmel, the founder of Jones Apparel Group, as well as through a total of $25 million in donations from a dozen others.

The center will be led by Drew Pardoll and is to focus on melanoma, colon, pancreatic, urologic, lung, breast, and ovarian cancers, according to the university.

"I don't want to leave the impression the federal government is the only answer. It's not," Biden said in speech after the institute's announcement, according to Stat News. "This is a great example of one of the core elements of the cancer moonshot task force: facilitating cooperation between government, the private sector, academia, and philanthropy."

The Scan

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.

Topical Compound to Block EGFR Inhibitors May Ease Skin Toxicities, Study Finds

A topical treatment described in Science Translational Medicine may limit skin toxicities seen with EGFR inhibitor therapy.

Dozen Genetic Loci Linked to Preeclampsia Risk in New GWAS

An analysis of genome-wide association study data in JAMA Cardiology finds genetic loci linked to preeclampsia that have ties to blood pressure.

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.